Cingulate CING
NASDAQ CING
$5.25 +0.02 (+0.38%)
As of: Sep 22, 2026 · 11:14 AM EDT

Cingulate (CING) Net Shares Issued and Repurchased (2021 - 2026)

Cingulate's (CING) quarterly Net Shares Issued and Repurchased came in at $3860.0 in Q2 2026, down 93.67% on a YoY basis from $61005.0 in Q2 2025, and down 99.56% quarter-over-quarter from $868901.0 in Q4 2025.

Analysis

Cingulate (CING) Net Shares Issued and Repurchased (2021 - 2026) Analysis & Trends

Cingulate (CING) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $3860.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Shares Issued and Repurchased fell 93.67% year-over-year to $3860.0; the trailing twelve-month figure through Jun 2026 stood at $3860.0 (down 93.67% YoY), and the FY2025 full-year result was $868901.0, up 875.94% from the prior year.
  • Net Shares Issued and Repurchased retreated to $3860.0 in Q2 2026 per CING's latest filing, from $868901.0 in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at $868901.0 in Q4 2025 and bottomed at $2000.0 in Q3 2024.
  • Historically, Net Shares Issued and Repurchased has averaged $151355.9 across 5 years, with a median of $61005.0 in 2025.
  • The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased tumbled 98.08% in 2024, then jumped 27541.9% in 2025.
  • Over 5 years, Net Shares Issued and Repurchased stood at $18017.0 in 2022, then sank by 85.29% to $2651.0 in 2023, then soared by 3258.43% to $89032.0 in 2024, then jumped by 875.94% to $868901.0 in 2025, then plunged by 99.56% to $3860.0 in 2026.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $3860.0, $868901.0, and $552838.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -3.07 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Cingulate 72.81 Mn 72.81 Mn - 3,860.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,860.00
Dec 31, 2025 868,901.00
Sep 30, 2025 552,838.00
Jun 30, 2025 61,005.00
Mar 31, 2025 248,428.00
Dec 31, 2024 89,032.00
Sep 30, 2024 2,000.00
Jun 30, 2024 69,038.00
Mar 31, 2024 15,994.00
Dec 31, 2023 2,651.00
Sep 30, 2023 104,066.00
Jun 30, 2023 127,758.00
Mar 31, 2023 19,225.00
Dec 31, 2022 18,017.00
Sep 30, 2022 29,721.00
Jun 30, 2022 17,517.00
Mar 31, 2022 342,999.00
Dec 31, 2021 523,285.00
API Access

Cingulate Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=CING&period=max&api_key=YOUR_API_KEY